Nazzari E, Buzzetti R, Mozzillo E. Conoscere ed interpretare le differenze –RANDOMIZED TRIAL OF THE INSULIN-ONLY ILET BIONIC PANCREAS FOR THE TREATMENT OF CYSTIC FIBROSIS – RELATED DIABETES. Orizzonti FC, 2024;20 (1):21-23
Articolo
-
-
Picca M, Romeo Carrozzo R, Milani GP, Corsello A, Macchi M, Buzzetti R, Marchisio P, Chiara Mameli C. Leading reasons for antibiotic prescriptions in pediatric respiratory infections: influence of fever in a primary care setting. Italian Journal of Pediatrics, 2023;49(1):131-
-
Tosco A, Poli P, Casale A, De Gregorio F, Sepe A, Buonpensiero P, Di Pasqua A, Castaldo A, Cimbalo C, Buzzetti R, Raia V, Berlucchi M, Timpano S, Badolato R, Padoan R, Orlando C. The Role of Bronchoscopy in the Management of Children With Cystic Fibrosis. J Bronchol Intervent Pulmonol, 2023;30:258-267
-
Buzzetti R, Cirilli N, Raia V, Salvatore D, Daniele A. DAL CYSTIC FIBROSIS DATABASE (CFDB): QUANDO UNA COPPIA E’ A RISCHIO DI AVERE UN FIGLIO AFFETTO DA FIBROSI CISTICA. Orizzonti FC, 2023;20 (3):35-37
-
Buzzetti R, Minicucci L, Cirilli N, Raia V, Salvatore D, Daniele A. Medicina delle evidenze - DAL CYSTIC FIBROSIS DATABASE (CFDB): STATO NUTRIZIONALE NON ADEGUATO, COSA FARE?. Orizzonti FC, 2023;20 (2):35-38
-
Cresta F, Buzzetti R, Bertolo S. Conoscere ed interpretare le differenze – THE EFFECT OF INHALED HYPERTONIC SALINE ON LUNG STRUCTURE IN CHILDREN AGED 3-6 YEARS WITH CYSTIC FIBROSIS (SHIP-CT): A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL. Orizzonti FC, 2023;20 (2):28-32
-
Cresta F, Buzzetti R, Braggion C. Conoscere ed interpretare le differenze – EMBEDDED SPECIALIST PALLIATIVE CARE IN CYSTIC FIBROSIS: RESULTS OF RANDOMIZED FEASIBILITY CLINICAL TRIAL. Orizzonti FC, 2023;20 (2):32-34
-
Lucca F, Buzzetti R, Braggion C. Conoscere ed interpretare le differenze – EFFECT OF AIRWAY CLEARANCE THERAPIES ON MUCOCILIARY CLEARANCE IN ADULTS WITH CYSTIC FIBROSIS: A RANDOMIZED CONTROLLED TRIAL. Orizzonti FC, 2023;20 (3):31-34
-
Lucca F, Buzzetti R, Di Leonardo A. Conoscere ed interpretare le differenze – INHALED MRNA THERAPY FOR TREATMENT OF CYSTIC FIBROSIS: INTERIM RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1/2 CLINICAL STUDY. Orizzonti FC, 2023;20 (3):27-31
-
Majo F, Buzzetti R, Minicucci L. Conoscere ed interpretare le differenze – Commenti ad articoli della letteratura. THE EFFECT OF AZITHROMYCIN ON STRUCTURAL LUNG DISEASE IN INFANTS WITH CYSTIC FIBROSIS (COMBACT CF): A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED CLINICAL TRIAL. Orizzonti FC, 2023;20 (1):28-30
© 2022 Roberto Buzzetti - P. iva: 02926830163 - Developed by Onlime